13 results on '"Sharpe, Arlene H."'
Search Results
2. Programmed Death-1 Ligand 2-Mediated Regulation of the PD-L1 to PD-1 Axis Is Essential for Establishing CD4+ T Cell Immunity.
- Author
-
Karunarathne, Deshapriya S., Horne-Debets, Joshua M., Huang, Johnny X., Faleiro, Rebecca, Leow, Chiuan Yee, Amante, Fiona, Watkins, Thomas S., Miles, John J., Dwyer, Patrick J., Stacey, Katryn J., Yarski, Michael, Poh, Chek Meng, Lee, Jason S., Cooper, Matthew A., Rénia, Laurent, Richard, Derek, McCarthy, James S., Sharpe, Arlene H., and Wykes, Michelle N.
- Subjects
- *
PLASMODIUM , *APOPTOSIS , *LIGANDS (Biochemistry) , *CD4 antigen , *T cells , *IMMUNOREGULATION , *DENDRITIC cells , *PHYSIOLOGY - Abstract
Summary Many pathogens, including Plasmodium spp., exploit the interaction of programmed death-1 (PD-1) with PD-1-ligand-1 (PD-L1) to “deactivate” T cell functions, but the role of PD-L2 remains unclear. We studied malarial infections to understand the contribution of PD-L2 to immunity. Here we have shown that higher PD-L2 expression on blood dendritic cells, from Plasmodium falciparum- infected individuals, correlated with lower parasitemia. Mechanistic studies in mice showed that PD-L2 was indispensable for establishing effective CD4 + T cell immunity against malaria, because it not only inhibited PD-L1 to PD-1 activity but also increased CD3 and inducible co-stimulator (ICOS) expression on T cells. Importantly, administration of soluble multimeric PD-L2 to mice with lethal malaria was sufficient to dramatically improve immunity and survival. These studies show immuno-regulation by PD-L2, which has the potential to be translated into an effective treatment for malaria and other diseases where T cell immunity is ineffective or short-lived due to PD-1-mediated signaling. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
3. Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family.
- Author
-
Schildberg, Frank A., Klein, Sarah R., Freeman, Gordon J., and Sharpe, Arlene H.
- Subjects
- *
RECEPTOR-ligand complexes , *IMMUNE response , *IMMUNITY , *HOMEOSTASIS , *INFECTION - Abstract
Immune responses need to be controlled for optimal protective immunity and tolerance. Coinhibitory pathways in the B7-CD28 family provide critical inhibitory signals that regulate immune homeostasis and defense and protect tissue integrity. These coinhibitory signals limit the strength and duration of immune responses, thereby curbing immune-mediated tissue damage, regulating resolution of inflammation, and maintaining tolerance to prevent autoimmunity. Tumors and microbes that cause chronic infections can exploit these coinhibitory pathways to establish an immunosuppressive microenvironment, hindering their eradication. Advances in understanding T cell coinhibitory pathways have stimulated a new era of immunotherapy with effective drugs to treat cancer, autoimmune and infectious diseases, and transplant rejection. In this review we discuss the current knowledge of the mechanisms underlying the coinhibitory functions of pathways in the B7-CD28 family, the diverse functional consequences of these inhibitory signals on immune responses, and the overlapping and unique functions of these key immunoregulatory pathways. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
4. ICOS:ICOS-Ligand Interaction Is Required for Type 2 Innate Lymphoid Cell Function, Homeostasis, and Induction of Airway Hyperreactivity.
- Author
-
Maazi, Hadi, Patel, Nisheel, Sankaranarayanan, Ishwarya, Suzuki, Yuzo, Rigas, Diamanda, Soroosh, Pejman, Freeman, Gordon J., Sharpe, Arlene H., and Akbari, Omid
- Subjects
- *
LIGANDS (Biochemistry) , *HOMEOSTASIS , *NATURAL immunity , *ASTHMA , *CYTOKINES , *EOSINOPHILIA - Abstract
Summary Allergic asthma is caused by Th2-cell-type cytokines in response to allergen exposure. Type 2 innate lymphoid cells (ILC2s) are a newly identified subset of immune cells that, along with Th2 cells, contribute to the pathogenesis of asthma by producing copious amounts of IL-5 and IL-13, which cause eosinophilia and airway hyperreactivity (AHR), a cardinal feature of asthma. ILC2s express ICOS, a T cell costimulatory molecule with a currently unknown function. Here we showed that a lack of ICOS on murine ILC2s and blocking the ICOS:ICOS-ligand interaction in human ILC2s reduced AHR and lung inflammation. ILC2s expressed both ICOS and ICOS-ligand, and the ICOS:ICOS-ligand interaction promoted cytokine production and survival in ILC2s through STAT5 signaling. Thus, ICOS:ICOS-ligand signaling pathway is critically involved in ILC2 function and homeostasis. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
5. The Coinhibitory Receptor CTLA-4 Controls B Cell Responses by Modulating T Follicular Helper, T Follicular Regulatory, and T Regulatory Cells.
- Author
-
Sage, Peter T., Paterson, Alison M., Lovitch, Scott B., and Sharpe, Arlene H.
- Subjects
- *
CYTOTOXIC T lymphocyte-associated molecule-4 , *B cells , *T helper cells , *ANTIBODY formation , *LABORATORY mice , *IMMUNOSPECIFICITY , *IMMUNOSUPPRESSION - Abstract
Summary The receptor CTLA-4 has been implicated in controlling B cell responses, but the mechanisms by which CTLA-4 regulates antibody production are not known. Here we showed deletion of CTLA-4 in adult mice increased Tfh and Tfr cell numbers and augmented B cell responses. In the effector phase, loss of CTLA-4 on Tfh cells resulted in heightened B cell responses, whereas loss of CTLA-4 on Tfr cells resulted in defective suppression of antigen-specific antibody responses. We also found that non-Tfr Treg cells could suppress B cell responses through CTLA-4 and that Treg and/or Tfr cells might downregulate B7-2 on B cells outside germinal centers as a means of suppression. Within the germinal center, however, Tfr cells potently suppress B cells through CTLA-4, but with a mechanism independent of altering B7-1 or B7-2. Thus, we identify multifaceted regulatory roles for CTLA-4 in Tfh, Tfr, and Treg cells, which together control humoral immunity. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
6. Treg Cells Expressing the Coinhibitory Molecule TIGIT Selectively Inhibit Proinflammatory Th1 and Th17 Cell Responses.
- Author
-
Joller, Nicole, Lozano, Ester, Burkett, Patrick?R., Patel, Bonny, Xiao, Sheng, Zhu, Chen, Xia, Junrong, Tan, Tze?G., Sefik, Esen, Yajnik, Vijay, Sharpe, Arlene?H., Quintana, Francisco?J., Mathis, Diane, Benoist, Christophe, Hafler, David?A., and Kuchroo, Vijay?K.
- Subjects
- *
T helper cells , *CELLULAR control mechanisms , *INFLAMMATION , *ENZYME inhibitors , *IMMUNE response , *CELL proliferation - Abstract
Summary: Foxp3+ T regulatory (Treg) cells regulate immune responses and maintain self-tolerance. Recent work shows that Treg cells are comprised of many subpopulations with specialized regulatory functions. Here we identified Foxp3+ T cells expressing the coinhibitory molecule TIGIT as a distinct Treg cell subset that specifically suppresses proinflammatory T helper 1 (Th1) and Th17 cell, but not Th2 cell responses. Transcriptional profiling characterized TIGIT+ Treg cells as an activated Treg cell subset with high expression of Treg signature genes. Ligation of TIGIT on Treg cells induced expression of the effector molecule fibrinogen-like protein 2 (Fgl2), which promoted Treg-cell-mediated suppression of T effector cell proliferation. In addition, Fgl2 was necessary to prevent suppression of Th2 cytokine production in a model of allergic airway inflammation. TIGIT expression therefore identifies a Treg cell subset that demonstrates selectivity for suppression of Th1 and Th17 cell but not Th2 cell responses. [Copyright &y& Elsevier]
- Published
- 2014
- Full Text
- View/download PDF
7. Circulatory Antigen Processing by Mucosal Dendritic Cells Controls CD8+ T Cell Activation
- Author
-
Chang, Sun-Young, Song, Joo-Hye, Guleng, Bayasi, Cotoner, Carmen Alonso, Arihiro, Seiji, Zhao, Yun, Chiang, Hao-Sen, O’Keeffe, Michael, Liao, Gongxian, Karp, Christopher L., Kweon, Mi-Na, Sharpe, Arlene H., Bhan, Atul, Terhorst, Cox, and Reinecker, Hans-Christian
- Subjects
- *
ANTIGEN processing , *MUCOUS membranes , *DENDRITIC cells , *CD8 antigen , *T cells , *SMALL intestine immunology , *LYMPHATICS , *IMMUNE response - Abstract
Summary: Circulatory antigens transit through the small intestine via the fenestrated capillaries in the lamina propria prior to entering into the draining lymphatics. But whether or how this process controls mucosal immune responses remains unknown. Here we demonstrate that dendritic cells (DCs) of the lamina propria can sample and process both circulatory and luminal antigens. Surprisingly, antigen cross-presentation by resident CX3CR1+ DCs induced differentiation of precursor cells into CD8+ T cells that expressed interleukin-10 (IL-10), IL-13, and IL-9 and could migrate into adjacent compartments. We conclude that lamina propria CX3CR1+ DCs facilitate the surveillance of circulatory antigens and act as a conduit for the processing of self- and intestinally absorbed antigens, leading to the induction of CD8+ T cells, that partake in the control of T cell activation during mucosal immune responses. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
8. Interleukin-27 Priming of T Cells Controls IL-17 Production In trans via Induction of the Ligand PD-L1
- Author
-
Hirahara, Kiyoshi, Ghoreschi, Kamran, Yang, Xiang-Ping, Takahashi, Hayato, Laurence, Arian, Vahedi, Golnaz, Sciumè, Giuseppe, Hall, Aisling O'Hara, Dupont, Christopher D., Francisco, Loise M., Chen, Qian, Tanaka, Masao, Kanno, Yuka, Sun, Hong-Wei, Sharpe, Arlene H., Hunter, Christopher A., and O'Shea, John J.
- Subjects
- *
INTERLEUKINS , *T cells , *LIGANDS (Biochemistry) , *CELLULAR signal transduction , *IMMUNOSUPPRESSIVE agents , *CYTOKINES - Abstract
Summary: Interleukin-27 (IL-27) is a key immunosuppressive cytokine that counters T helper 17 (Th17) cell-mediated pathology. To identify mechanisms by which IL-27 might exert its immunosuppressive effect, we analyzed genes in T cells rapidly induced by IL-27. We found that IL-27 priming of naive T cells upregulated expression of programmed death ligand 1 (PD-L1) in a signal transducer and activator of transcription 1 (STAT1)-dependent manner. When cocultured with naive CD4+ T cells, IL-27-primed T cells inhibited the differentiation of Th17 cells in trans through a PD-1-PD-L1 interaction. In vivo, coadministration of naive TCR transgenic T cells (2D2 T cells) with IL-27-primed T cells expressing PD-L1 inhibited the development of Th17 cells and protected from severe autoimmune encephalomyelitis. Thus, these data identify a suppressive activity of IL-27, by which CD4+ T cells can restrict differentiation of Th17 cells in trans. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
9. Interleukin-4 Production by Follicular Helper T Cells Requires the Conserved Il4 Enhancer Hypersensitivity Site V
- Author
-
Vijayanand, Pandurangan, Seumois, Grégory, Simpson, Laura J., Abdul-Wajid, Sarah, Baumjohann, Dirk, Panduro, Marisella, Huang, Xiaozhu, Interlandi, Jeneen, Djuretic, Ivana M., Brown, Daniel R., Sharpe, Arlene H., Rao, Anjana, and Ansel, K. Mark
- Subjects
- *
INTERLEUKIN-4 , *T cells , *ALLERGIES , *LYMPHOID tissue , *IMMUNE response , *MOLECULAR biology , *IMMUNOGLOBULIN G - Abstract
Summary: Follicular helper T cells (Tfh cells) are the major producers of interleukin-4 (IL-4) in secondary lymphoid organs where humoral immune responses develop. Il4 regulation in Tfh cells appears distinct from the classical T helper 2 (Th2) cell pathway, but the underlying molecular mechanisms remain largely unknown. We found that hypersensitivity site V (HS V; also known as CNS2), a 3′ enhancer in the Il4 locus, is essential for IL-4 production by Tfh cells. Mice lacking HS V display marked defects in type 2 humoral immune responses, as evidenced by abrogated IgE and sharply reduced IgG1 production in vivo. In contrast, effector Th2 cells that are involved in tissue responses were far less dependent on HS V. HS V facilitated removal of repressive chromatin marks during Th2 and Tfh cell differentiation and increased accessibility of the Il4 promoter. Thus, Tfh and Th2 cells utilize distinct but overlapping molecular mechanisms to regulate Il4, a finding with important implications for understanding the molecular basis of allergic diseases. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
10. TIM-1 and TIM-4 Glycoproteins Bind Phosphatidylserine and Mediate Uptake of Apoptotic Cells
- Author
-
Kobayashi, Norimoto, Karisola, Piia, Peña-Cruz, Victor, Dorfman, David M., Jinushi, Masahisa, Umetsu, Sarah E., Butte, Manish J., Nagumo, Haruo, Chernova, Irene, Zhu, Baogong, Sharpe, Arlene H., Ito, Susumu, Dranoff, Glenn, Kaplan, Gerardo G., Casasnovas, Jose M., Umetsu, Dale T., DeKruyff, Rosemarie H., and Freeman, Gordon J.
- Subjects
- *
ANTIGEN-antibody reactions , *PHAGOCYTOSIS , *KILLER cells , *IMMUNOGLOBULINS - Abstract
Summary: The T cell immunoglobulin mucin (TIM) proteins regulate T cell activation and tolerance. Here we showed that TIM-4 is expressed on human and mouse macrophages and dendritic cells, and both TIM-4 and TIM-1 specifically bound phosphatidylserine (PS) on the surface of apoptotic cells but not any other phospholipid tested. TIM-4+ peritoneal macrophages, TIM-1+ kidney cells, and TIM-4- or TIM-1-transfected cells efficiently phagocytosed apoptotic cells, and phagocytosis could be blocked by TIM-4 or TIM-1 monoclonal antibodies. Mutations in the unique cavity of TIM-4 eliminated PS binding and phagocytosis. TIM-4 mAbs that blocked PS binding and phagocytosis mapped to epitopes in this binding cavity. These results show that TIM-4 and TIM-1 are immunologically restricted members of the group of receptors whose recognition of PS is critical for the efficient clearance of apoptotic cells and prevention of autoimmunity. [Copyright &y& Elsevier]
- Published
- 2007
- Full Text
- View/download PDF
11. Programmed Death-1 Ligand 1 Interacts Specifically with the B7-1 Costimulatory Molecule to Inhibit T Cell Responses
- Author
-
Butte, Manish J., Keir, Mary E., Phamduy, Theresa B., Sharpe, Arlene H., and Freeman, Gordon J.
- Subjects
- *
T cells , *MOLECULES , *CYTOKINES , *LYMPHOCYTES - Abstract
Summary: Pathways in the B7:CD28 family of costimulatory molecules regulate T cell activation and tolerance. B7-dependent responses in Cd28−/−Ctla4−/− T cells together with reports of stimulatory and inhibitory functions for Programmed Death-1 Ligand 1 or 2 molecules (PD-L1 or PD-L2) have suggested additional receptors for these B7 family members. We show that B7-1 and PD-L1 interacted with affinity intermediate to that of B7-1:CD28 and B7-1:CTLA-4. The PD-L1:B7-1 interface overlapped with the B7-1:CTLA-4 and PD-L1:PD-1 (Programmed Death-1) interfaces. T cell activation and cytokine production were inhibited by the interaction of B7-1 with PD-L1. The responses of PD-1-deficient versus PD-1,B7-1 double-deficient T cells to PD-L1 and of CD28,CTLA-4 double-deficient versus CD28,CTLA-4,PD-L1 triple-deficient T cells to B7-1 demonstrated that PD-L1 and B7-1 interact specifically to inhibit T cell activation. Our findings point to a substantial bidirectional inhibitory interaction between B7-1 and PD-L1 and add an additional dimension to immunoregulatory functions of the B7:CD28 family. [Copyright &y& Elsevier]
- Published
- 2007
- Full Text
- View/download PDF
12. An Autoimmune Disease-Associated CTLA-4 Splice Variant Lacking the B7 Binding Domain Signals Negatively in T Cells
- Author
-
Vijayakrishnan, Lalitha, Slavik, Jacqueline M., Illés, Zsolt, Greenwald, Rebecca J., Rainbow, Dan, Greve, Bernhard, Peterson, Laurence B., Hafler, David A., Freeman, Gordon J., Sharpe, Arlene H., Wicker, Linda S., and Kuchroo, Vijay K.
- Subjects
- *
AUTOIMMUNE diseases , *T cells , *LYMPHOCYTES , *PROTEINS - Abstract
Cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) plays a critical role in downregulating T cell responses. A number of autoimmune diseases have shown genetic linkage to the CTLA-4 locus. We have cloned and expressed an alternatively spliced form of CTLA-4 that has genetic linkage with type I diabetes in the NOD mice. This splice variant of CTLA-4, named ligand-independent CTLA-4 (liCTLA-4), lacks exon2 including the MYPPPY motif essential for binding to the costimulatory ligands B7-1 and B7-2. Here we show that liCTLA-4 is expressed as a protein in primary T cells and strongly inhibits T cell responses by binding and dephosphorylating the TcRζ chain. Expression of liCTLA-4, but not full-length CTLA-4 (flCTLA-4), was higher in memory/regulatory T cells from diabetes-resistant NOD congenic mice compared to susceptible NOD mice. These data suggest that increased expression and negative signaling delivered by the liCTLA-4 may regulate development of T cell-mediated autoimmune diseases. [Copyright &y& Elsevier]
- Published
- 2004
- Full Text
- View/download PDF
13. A Cre-driven allele-conditioning line to interrogate CD4+ conventional T cells.
- Author
-
Andrews, Lawrence P., Vignali, Kate M., Szymczak-Workman, Andrea L., Burton, Amanda R., Brunazzi, Erin A., Ngiow, Shin Foong, Harusato, Akihito, Sharpe, Arlene H., Wherry, E. John, Taniuchi, Ichiro, Workman, Creg J., and Vignali, Dario A.A.
- Subjects
- *
REGULATORY T cells , *T cells , *DELETION mutation - Abstract
CD4+ T cells share common developmental pathways with CD8+ T cells, and upon maturation, CD4+ T conventional T (Tconv) cells lack phenotypic markers that distinguish these cells from FoxP3+ T regulatory cells. We developed a tamoxifen-inducible ThPOK CreERT2.hCD2 line with Frt sites inserted on either side of the CreERT2-hCD2 cassette, and a Foxp3 Ametrine-FlpO strain, expressing Ametrine and FlpO in Foxp3+ cells. Breeding these mice resulted in a CD4conviCreERT2-hCD2 line that allows for the specific manipulation of a gene in CD4+ Tconv cells. As FlpO removes the CreERT2-hCD2 cassette, CD4+ Treg cells are spared from Cre activity, which we refer to as allele conditioning. Comparison with an E8IiCreERT2.GFP mouse that enables inducible targeting of CD8+ T cells, and deletion of two inhibitory receptors, PD-1 and LAG-3, in a melanoma model, support the fidelity of these lines. These engineered mouse strains present a resource for the temporal manipulation of genes in CD4+ T cells and CD4+ Tconv cells. [Display omitted] • ThPOK CreERT2.hCD2 mice restrict Cre activity to CD4+ T cells • Foxp3 Ametrine-FlpO and ThPOK F/F.iCreERT2.hCD2 mice generate a CD4conviCreERT2-hCD2 line • CD4+ Tconv cell-type restriction of Cre activity obtained using allele conditioning • CD4conviCreERT2-hCD2 selectively removed PD-1 and LAG-3 on CD4+ Tconv cells only CD4+ T cell subpopulations have been difficult to genetically interrogate because of shared pathways with CD8+ T cells during T cell development. Using an allele-conditioning strategy, Andrews et al. generate murine lines that temporally restrict Cre activity and gene deletion to CD4+ T conventional cells, while sparing CD4+ T regulatory cells. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.